An independent player specialized in the Diagnostic Imaging Business.
A solutions portfolio available for all the main key modalities, including: X-ray Imaging (conventional X-ray and Computed Tomography), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound and Nuclear Medicine through radioactive tracers. The portfolio offering has been broadened with the acquisition of E-Z-EM, Inc in 2008, a major manufacturer of contrast media and medical devices for gastrointestinal (GI) applications, and Swiss Medical Care in 2011, now Bracco Injeenering, which allowed Bracco to strengthen its portfolio of automated systems for the administration of contrast media.
Operating in over 90 markets worldwide, either directly or indirectly through subsidiaries, joint ventures, license and distribution partnership agreements, with a strong presence in key geographies.
A successful track record in the development of clinically important products and related services to support clinical professionals to optimize diagnostic procedures.
An innovative R&D player with efficient process oriented approach: R&D activities located in 3 integrated and specialized research centers in Italy, Switzerland and the United States and collaborations in place with major institutions and universities worldwide.
Manufacturing activities located in Italy (Ceriano Laghetto, Torviscosa, and Colleretto Giacosa), Switzerland (Geneva), Japan (Saitama) and China (Shanghai).
A continuous path to innovation, addressing unmet medical needs and improving production processes efficiency.
A successful entrepreneurial tradition combined with solid managerial experience.